Clinical Trial Update: Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated prolonged-release fampridine as an adjunct to active motor training in patients with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Fampridine (4-aminopyridine)

Snippet

Sponsor: Clinique Neuro-Outaouais | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED